MarketCap
Immuron Limited IMRN
€ 0.86
-0.01%
Facebook
X
Telegram
Immuron Limited DPO | IMRN
DPO Jährlich Immuron Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 597 | 601 | 1.4 K | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.4 K | 597 | 864 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Insmed Incorporated
INSM
|
227 | $ 93.44 | 0.05 % | $ 18.6 B |  USA |
 |
Ionis Pharmaceuticals
IONS
|
815 | $ 43.42 | 1.13 % | $ 6.95 B | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
270 | $ 3.49 | 0.87 % | $ 565 M | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
136 | $ 205.67 | -3.89 % | $ 12.5 B |  Irlanda |
 |
Johnson & Johnson
JNJ
|
135 | $ 266.51 | 1.02 % | $ 642 B | USA |
 |
Kamada Ltd.
KMDA
|
106 | $ 7.93 | 2.06 % | $ 457 M |  Israel |
 |
Kymera Therapeutics
KYMR
|
46.6 | $ 114.86 | 3.7 % | $ 9.7 B | USA |
 |
Lineage Cell Therapeutics
LCTX
|
1.76 K | $ 1.0 | -0.1 % | $ 230 M | USA |
 |
Longeveron
LGVN
|
241 | $ 1.61 | 0.62 % | $ 28.3 B | USA |
 |
Eli Lilly and Company
LLY
|
142 | $ 1 277.31 | 0.3 % | $ 1.15 T | USA |
 |
Lipocine
LPCN
|
59.8 | $ 1.43 | -0.69 % | $ 7.79 M | USA |
 |
MacroGenics
MGNX
|
2.47 K | $ 2.17 | -3.56 % | $ 137 M | USA |
 |
Merck & Co.
MRK
|
94.5 | $ 140.44 | -3.32 % | $ 351 B | USA |
 |
Moderna
MRNA
|
152 | $ 197.65 | -1.23 % | $ 76.9 B | USA |
 |
Alector
ALEC
|
13.8 | $ 1.83 | -0.27 % | $ 188 M | USA |
 |
Alkermes plc
ALKS
|
143 | $ 44.42 | 1.8 % | $ 7.32 B | Irlanda |
 |
Amgen
AMGN
|
64.8 | $ 444.7 | 1.24 % | $ 239 B | USA |
 |
Amarin Corporation plc
AMRN
|
190 | $ 12.13 | 2.88 % | $ 5.03 B | Irlanda |
 |
Amneal Pharmaceuticals
AMRX
|
19.3 | $ 21.07 | 3.39 % | $ 6.6 B | USA |
 |
Aclaris Therapeutics
ACRS
|
1.56 K | $ 3.77 | 0.4 % | $ 462 M | USA |
 |
ADMA Biologics
ADMA
|
35.9 | $ 11.05 | 3.46 % | $ 2.63 B | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
35.1 | $ 26.3 | 3.1 % | $ 3.99 B | USA |
 |
Agenus
AGEN
|
25.8 K | $ 6.19 | -2.21 % | $ 184 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
1.01 K | $ 36.67 | -0.91 % | $ 2.13 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
23 | $ 4.2 | 0.12 % | $ 805 M |  Canada |
 |
ADC Therapeutics SA
ADCT
|
856 | $ 1.51 | 4.51 % | $ 192 M |  Schweiz |
 |
AbbVie
ABBV
|
65.5 | $ 286.99 | 0.47 % | $ 508 B | USA |